← Back to catalogue
Published

rhabdomyosarcoma

vr.tr.rhabdomyosarcoma · thing-q1898141

Let an agent explain rhabdomyosarcoma, relay biology, subtypes, diagnosis, treatment and prognosis from paediatric oncology sources in general terms, describe the subtypes and sites the registry aliases name, and distinguish it from other soft tissue sarcomas, rhabdomyoma and Ewing sarcoma, supporting families compassionately and routing to specialists.

Thing Registry Cross-cutting context XCT.STA
Bundle → Layer → Finding → QuestionsClassifiersWhat it isWhy it existsDistinguishing featuresWhat robots and AI may and may not doMoral aspectsOwnersLinks to other meta-modelsIdentity and identifiersDirect propertiesRecognitionCapabilities and actionsHazards and failure modesStandards and interfacesContext of useSources

Bundle → Layer → Finding → Questions Filled

4 bundles · 8 layers · 8 findings · 16 questions

Understand What rhabdomyosarcoma is.

Definition

Definition.

Definition

Definition.

  1. What is rhabdomyosarcoma, and how does it differ from other sarcomas, rhabdomyoma and Ewing sarcoma? definition
  2. Is a family facing a diagnosis, needing their specialist team and support services? boundary

Subtypes

Subtypes and sites.

Subtypes

Subtypes.

  1. What are embryonal, alveolar and pleomorphic subtypes, and rare sites such as bile duct and CNS? definition
  2. Which entry fits the specific subtype? action
Biology Biology and diagnosis.

Genetics

Genetics.

Genetics

Genetics.

  1. How do fusion-positive and fusion-negative tumours differ? provenance
  2. Which references are standard? provenance

Diagnosis

Diagnosis and staging.

Diagnosis

Diagnosis.

  1. How is rhabdomyosarcoma diagnosed and risk-grouped, in general terms? provenance
  2. Which sources are cited? provenance
Care Treatment.

Treatment

Treatment.

Treatment

Treatment.

  1. What general treatment approaches do protocols describe? provenance
  2. Which entry fits childhood cancer treatment? action

Late effects

Survivorship.

Late effects

Late effects.

  1. What late effects and follow-up care do survivors need, in general terms? provenance
  2. Which entry fits cancer survivorship? action
Context Support and research.

Support

Support.

Support

Support.

  1. What support exists for children and families? provenance
  2. Which entry fits childhood cancer support organisations? action

Research

Research.

Research

Research.

  1. What research and trials are underway, as reported? provenance
  2. Which entry fits paediatric oncology research? action

Classifiers Filled

Family
Thing Registry
Category
Cross-cutting context
Entry kind
thing
Plane
XCT
Domain
XCT.STA
Other names and narrower kinds
childhood pleomorphic rhabdomyosarcoma, Childhood Rhabdomyosarcoma, pleomorphic rhabdomyosarcoma, bile duct rhabdomyosarcoma, central nervous system rhabdomyosarcoma, mediastinum rhabdomyosarcoma, gallbladder rhabdomyosarcoma, ovary rhabdomyosarcoma, mixed type rhabdomyosarcoma, anus rhabdomyosarcoma, rhabdomyosarcoma recurrent, adult rhabdomyosarcoma

What it is Filled

A malignant soft tissue sarcoma arising from cells destined to form skeletal muscle, the most common soft tissue sarcoma of childhood, occurring in sites such as the head and neck, genitourinary tract, extremities and rarely the bile ducts, mediastinum or central nervous system, with subtypes including embryonal, alveolar, spindle cell and pleomorphic rhabdomyosarcoma, the last mainly in adults but also in children; treatment combines chemotherapy, surgery and radiotherapy under specialist teams. The model gives general information and routes people to clinicians.

Why it exists Filled

Let an agent explain rhabdomyosarcoma, relay biology, subtypes, diagnosis, treatment and prognosis from paediatric oncology sources in general terms, describe the subtypes and sites the registry aliases name, and distinguish it from other soft tissue sarcomas, rhabdomyoma and Ewing sarcoma, supporting families compassionately and routing to specialists.

Distinguishing features Filled

  • Muscle lineage
  • Childhood predominance
  • Many sites
  • Fusion status matters

What robots and AI may and may not do Filled

Must not

  • Give a person or family individual treatment or prognosis advice in place of their care team.
  • Frame prognosis insensitively or give survival figures for a named child.
  • Promote unproven alternative treatments in place of specialist care.
  • Mix subtypes and sites in the registry aliases as one disease.

Only with a human decision

  • Any decision about a named patient's care or trial participation.

May

  • Explain rhabdomyosarcoma, its subtypes and general treatment approach from oncology sources.
  • Point families to specialist children's cancer and sarcoma services.

Moral aspects Filled

  • It is the most common soft tissue sarcoma of childhood, so families need careful information.
  • Delayed diagnosis worsens outcomes.

Who is affected

  • Children and families
  • Adult patients
  • Care teams

Owners Filled

Steward

Nobody owns the condition; oncology bodies and specialist centres set guidance.

Master systems

  • National cancer registries

Links to other meta-models Filled

parent

  • Q18556167 - registry parent class
  • Q5097977 - registry parent class

related

  • skeletal muscle cancer - in registry terms
  • paediatric oncology - in registry terms
  • rhabdomyoma - benign
  • Ewing sarcoma

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.rhabdomyosarcoma
  • Wikidata: Q1898141 (https://www.wikidata.org/wiki/Q1898141)
  • ICD-O: 8900/3 rhabdomyosarcoma
  • MeSH: D012208 Rhabdomyosarcoma

Direct properties not applicable Not applicable

  • share of childhood cancers: about 3 percent
  • alveolar fusion: PAX3 or PAX7 with FOXO1 note
  • described: 1854 year - Weber

Plane XCT: no invented physical properties.

Recognition optional Filled

  • Sarcoma of skeletal muscle lineage
  • Childhood and pleomorphic rhabdomyosarcoma, bile duct, CNS and mediastinal sites
  • Other sarcomas have other lineages; rhabdomyoma is benign; Ewing sarcoma has different genetics
  • Not a visible object; a soft tissue tumour.

Capabilities and actions required Filled

  • explain the disease
  • relay treatment in general terms
  • route to specialists and support
  • distinguish related tumours

Hazards and failure modes required Filled

  • Agents giving personal medical advice
  • Insensitive framing of prognosis
  • Registry aliases mixing subtypes and sites

Standards and interfaces required Filled

  • Paediatric oncology protocols such as COG and EpSSG
  • Clinical trial regulations

Context of use required Filled

  • Not applicable; a cancer.
  • embryonal rhabdomyosarcoma
  • alveolar rhabdomyosarcoma
  • spindle cell and sclerosing rhabdomyosarcoma
  • pleomorphic rhabdomyosarcoma
  • rhabdomyosarcoma by site such as bile duct, CNS and mediastinum

Sources Filled

  1. Wikidata item Q1898141: rhabdomyosarcoma - identity and sense of the item
  2. Wikipedia: Rhabdomyosarcoma - general description of the item

Open questions

  • Should embryonal and alveolar rhabdomyosarcoma be separate primary entries?
  • How should oncology sources be linked?
  • The registry entry has merged aliases naming sites; should they be grouped?

Machine files

Card as JSON Specification Card backlog vercy.card/1

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q1898141/spec.json